HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hogan, J. C. Articles by Stephens, J. M. Search for Related Content PubMed PubMed Citation Articles by Hogan, J. C. Articles by Stephens, J. M. Social Bookmarking                What's this?

The Regulation of Fatty Acid Synthase by STAT5A

From the Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana

Growth hormone (GH) diminishes adipose tissue mass in vivo and decreases expression and activity of fatty acid synthase (FAS) in adipocytes. GH and prolactin (PRL) are potent activators of STAT5 and exert adipogenic and antiadipogenic effects in adipocytes. In this study, we demonstrate that GH and PRL decrease the mRNA and protein levels of FAS in 3T3-L1 adipocytes. We present evidence that indicates that FAS is repressed at the level of transcription. In addition, PRL responsiveness was shown to exist between –1,594 and –700 of the rat FAS promoter. Moreover, responsiveness to PRL was abolished with mutation of a site at position –908 to –893, which we have shown to bind STAT5A in a PRL-dependent manner. Taken together, these data strongly suggest that PRL directly represses expression of FAS in adipocytes through STAT5A binding to the –908 to –893 site. Furthermore, our results indicate that STAT5A has an antilipogenic function in adipocytes and may contribute to the regulation of energy balance.

Abbreviations: DMEM, Dulbecco’s modified Eagle medium; EMSA, electromobility shift assays; FAS, fatty acid synthase; GH, growth hormone; LIF, leukemia inhibitory factor; LPL, lipoprotein lipase; PRL, prolactin; TK, thymidine kinase

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				U. A. White, A. A. Coulter, T. K. Miles, and J. M. Stephens The STAT5A-Mediated Induction of Pyruvate Dehydrogenase Kinase 4 Expression by Prolactin or Growth Hormone in Adipocytes Diabetes, June 1, 2007; 56(6): 1623 - 1629. [Abstract] [Full Text] [PDF]

				C. R. LaPensee, N. D. Horseman, P. Tso, T. D. Brandebourg, E. R. Hugo, and N. Ben-Jonathan The Prolactin-Deficient Mouse Has an Unaltered Metabolic Phenotype Endocrinology, October 1, 2006; 147(10): 4638 - 4645. [Abstract] [Full Text] [PDF]

				X. Zhang and F. L. Kiechle Fatty Acid Synthase and its mRNA Concentrations Are Decreased at Different Times Following Hoechst 33342-induced Apoptosis in BC3H-1 Myocytes. Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 185 - 193. [Abstract] [Full Text] [PDF]